Virtus Investment Advisers’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80.5K Buy
11,979
+2,914
+32% +$19.6K 0.03% 422
2025
Q1
$81.9K Buy
+9,065
New +$81.9K 0.02% 448